ammuno-z 20 mg/5ml tablet
am-europharma corporation - zinc sulfate monohydrate - tablet - 20 mg/5ml
ammuno-z 27.5mg/ml oral solution drops
am-europharma corporation - zinc sulfate monohydrate - oral solution drops - 27.5mg/ml
gel-malicid 200mg/100mg tablet
am-europharma corporation - aluminum hydroxide , magnesium hydroxide - tablet - 200mg/100mg
reevive fortified with ginseng 50 mg/40 mg tablet
am-europharma corporation - sildenafil citrate , planax ginseng - tablet - 50 mg/40 mg
anemifer 125mg/ml oral drops
am-europharma corporation - iron as ferrous sulfate heptahydrate - oral drops - 125mg/ml
anemifer 150 mg / 5 ml (equivalent to 30 mg elemental iron) syrup
am-europharma corporation - ferrous sulfate heptahydrate - syrup - 150 mg / 5 ml (equivalent to 30 mg elemental iron)
isoniazid 100mg/5ml syrup
am-europharma corporation - isoniazid - syrup - 100mg/5ml
none 500mg (equivalent to 568.18mg sodium ascorbate) capsule
am-europharma corporation - ascorbic acid - capsule - 500mg (equivalent to 568.18mg sodium ascorbate)
none 500mg ( equivalent to 568.18mg sodium ascorbate) capsule
am-europharma corporation - ascorbic acid - capsule - 500mg ( equivalent to 568.18mg sodium ascorbate)
rasitrio
novartis europharm ltd. - aliskiren, amlodipine, hydrochlorothiazide - hypertension - cardiovascular system - rasitrio is indicated for the treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of aliskiren, amlodipine and hydrochlorothiazide given concurrently at the same dose level as in the combination.